NIA Aleve Vs. Vioxx Alzheimer's Study To Produce Data By 2002
This article was originally published in The Tan Sheet
Executive Summary
A National Institute on Aging study comparing Bayer's OTC Aleve and Merck's Rx Vioxx in Alzheimer's patients will produce data in two and a half years.